Quick Answer
Traws Pharma, Inc. reported Stockholders Equity of -$31.63 million for fiscal year 2024.
Traws Pharma, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$31.63M | -396.4% |
| 2023 | $10.67M | -62.3% |
| 2022 | $28.31M | -38.6% |
| 2021 | $46.12M | +646.9% |
| 2020 | $6.17M | -46.6% |
| 2019 | $11.57M | +114.9% |
| 2018 | $5.39M | +146.1% |
| 2017 | -$11.69M | -372.1% |
| 2016 | $4.30M | -57.1% |
| 2015 | $10.01M | -56.0% |
| 2014 | $22.75M | -71.7% |
| 2013 | $80.41M | +150.8% |
| 2012 | -$158.31M | -14.4% |
| 2011 | -$138.42M | -27.3% |
| 2010 | -$108.72M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.54M | +323.6% | -45.0% |
| June 30, 2025 | $8.26M | +107.8% | +37.7% |
| March 31, 2025 | $6.00M | -0.2% | +119.0% |
| December 31, 2024 | -$31.63M | -396.4% | -1455.8% |
| September 30, 2024 | -$2.03M | -114.0% | +98.1% |
| June 30, 2024 | -$105.52M | -658.4% | -1854.3% |
| March 31, 2024 | $6.01M | -73.7% | -43.6% |
| December 31, 2023 | $10.67M | -62.3% | -26.5% |
- Traws Pharma, Inc. showed a decrease of -396.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2024 period, Traws Pharma, Inc.’s stockholders equity has grown by 70.9% (from -$108.72 million to -$31.63 million).
- The most recent figure is from Traws Pharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: